PL361452A1 - Kompozycja zawierająca drobne cząstki o spowolnionym uwalnianiu przeznaczona do zastosowania w tabletkach szybko rozpadających się w przedsionku jamyustnej, oraz sposób ich wytwarzania - Google Patents

Kompozycja zawierająca drobne cząstki o spowolnionym uwalnianiu przeznaczona do zastosowania w tabletkach szybko rozpadających się w przedsionku jamyustnej, oraz sposób ich wytwarzania

Info

Publication number
PL361452A1
PL361452A1 PL02361452A PL36145202A PL361452A1 PL 361452 A1 PL361452 A1 PL 361452A1 PL 02361452 A PL02361452 A PL 02361452A PL 36145202 A PL36145202 A PL 36145202A PL 361452 A1 PL361452 A1 PL 361452A1
Authority
PL
Poland
Prior art keywords
oral cavity
producing
fine grains
compositions containing
same
Prior art date
Application number
PL02361452A
Other languages
English (en)
Inventor
Tatsuki Shinoda
Atsushi Maeda
Naoki Itou
Takao Mizumoto
Shigeru Yamazaki
Yuuki Takaishi
Original Assignee
Yamanouchi Pharmaceutical Co.Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co.Ltd. filed Critical Yamanouchi Pharmaceutical Co.Ltd.
Publication of PL361452A1 publication Critical patent/PL361452A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02361452A 2001-07-27 2002-07-25 Kompozycja zawierająca drobne cząstki o spowolnionym uwalnianiu przeznaczona do zastosowania w tabletkach szybko rozpadających się w przedsionku jamyustnej, oraz sposób ich wytwarzania PL361452A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30830301P 2001-07-27 2001-07-27

Publications (1)

Publication Number Publication Date
PL361452A1 true PL361452A1 (pl) 2004-10-04

Family

ID=23193419

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02361452A PL361452A1 (pl) 2001-07-27 2002-07-25 Kompozycja zawierająca drobne cząstki o spowolnionym uwalnianiu przeznaczona do zastosowania w tabletkach szybko rozpadających się w przedsionku jamyustnej, oraz sposób ich wytwarzania

Country Status (18)

Country Link
US (2) US7255876B2 (pl)
EP (1) EP1413294B1 (pl)
JP (3) JP4019374B2 (pl)
KR (1) KR100530546B1 (pl)
CN (1) CN1473035B (pl)
AT (1) ATE482692T1 (pl)
AU (1) AU2002355222B2 (pl)
BR (1) BR0205509A (pl)
CA (1) CA2419089A1 (pl)
CZ (1) CZ14921U1 (pl)
DE (2) DE20220604U1 (pl)
ES (1) ES2351249T3 (pl)
HU (1) HUP0302351A3 (pl)
MX (1) MXPA03000985A (pl)
PL (1) PL361452A1 (pl)
RU (1) RU2245136C2 (pl)
WO (1) WO2003009831A1 (pl)
ZA (1) ZA200300647B (pl)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.
PT1443917E (pt) * 2001-11-07 2006-06-30 Synthon Bv Comprimidos de tamsulosina
JP4173670B2 (ja) * 2002-03-08 2008-10-29 旭化成ファーマ株式会社 口腔内崩壊製剤
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
DE10244504A1 (de) * 2002-09-25 2004-04-08 Capsulution Nanoscience Ag Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff
JP4523265B2 (ja) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 排尿障害治療用口腔内崩壊製剤
MXPA05009095A (es) * 2003-01-27 2006-05-19 Astellas Pharma Inc Particulas finas entericas de liberacion sostenida de tamsulosin o su sal y metodo de fabricacion de las mismas.
ZA200409537B (en) * 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
SI1473029T1 (en) * 2003-04-30 2005-10-31 Ferring B.V. Solid dosage form comprising desmopressin
ATE341312T1 (de) * 2003-05-20 2006-10-15 Ethypharm Sa Orale pharmazeutische zusammensetzung mit verzögerter freisetzung
EP1656126B1 (en) * 2003-08-12 2011-08-10 Kyungdong Pharm. Co., Ltd. Preparing method for controlled released type tablet comprising tamsulosin hcl and the tablet produced thereof
EP1673073A4 (en) * 2003-09-29 2012-03-21 Cj Cheiljedang Corp SLOW RELEASE FORMULATIONS
CN100438914C (zh) * 2003-10-15 2008-12-03 富士化学工业株式会社 用于口腔内快速崩解的片剂的组合物
WO2005037254A1 (ja) * 2003-10-15 2005-04-28 Fuji Chemical Industry Co., Ltd. 口腔内速崩壊性錠剤
DE10350322A1 (de) * 2003-10-23 2005-06-09 Coty B.V. Klimabeständiger kosmetischer Komplex
JPWO2005039542A1 (ja) * 2003-10-27 2007-02-15 アステラス製薬株式会社 口腔内崩壊錠用の薬物含有被覆微粒子
US8128958B2 (en) 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US8197846B2 (en) 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
WO2005053659A1 (en) * 2003-12-03 2005-06-16 Natco Pharma Limited An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
KR100582350B1 (ko) * 2004-02-17 2006-05-22 한미약품 주식회사 탐수로신 염산염의 경구투여용 조성물 및 이의 서방성과립 제제
JP2008502727A (ja) * 2004-06-10 2008-01-31 グラット エアー テクニクス インコーポレーテッド 徐放性基材医薬品製剤
DE102004028940A1 (de) * 2004-06-15 2006-01-12 Krka Tovarna Zdravil, D.D. Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
SI1618873T1 (sl) * 2004-07-14 2007-10-31 Siegfried Generics Int Ag Granulat za kontrolirano sproščanje tamsulozina, ki vsebuje alginat
PL204079B1 (pl) * 2004-08-12 2009-12-31 Inst Farmaceutyczny Stały doustny preparat chlorowodorku tamsulozyny o przedłużonym uwalnianiu i sposób jego wytwarzania
ES2550626T5 (es) 2005-02-25 2019-01-15 Takeda Pharmaceuticals Co Método para producir gránulos
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
WO2006115285A1 (ja) * 2005-04-21 2006-11-02 Takeda Pharmaceutical Company Limited 医薬組成物
CN101166543B (zh) * 2005-04-28 2014-07-16 卫材R&D管理有限公司 含抗痴呆药物的组合物
RU2283114C1 (ru) * 2005-06-07 2006-09-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Композиция, обладающая гепатопротекторной активностью и нормализующая обменные процессы
US20070048369A1 (en) * 2005-08-26 2007-03-01 National Starch And Chemical Investment Holding Corporation Mucosal delivery tablet
EP1941862A1 (en) * 2005-08-31 2008-07-09 Ezaki Glico Co., Ltd. Tablet for removal of tongue coating
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
EP1891946A1 (en) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
US20100062063A1 (en) 2006-09-15 2010-03-11 Astellas Pharma Inc. Light-stable solid pharmaceutical composition of ramosetron
WO2009051022A2 (en) 2007-10-19 2009-04-23 Otsuka Pharmaceutical Co., Ltd. Matrix-type pharmaceutical solid preparation
WO2009101021A2 (en) * 2008-02-13 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Estradiol-containing drug delivery system
CN102006857B (zh) * 2008-02-13 2013-06-26 拜耳先灵医药股份有限公司 具有稳定作用的药物递送系统
JP5572321B2 (ja) * 2008-03-07 2014-08-13 沢井製薬株式会社 被覆微粒子含有口腔内崩壊錠
ES2332168B1 (es) * 2008-04-30 2010-10-27 Consejo Superior De Investigaciones Cientificas (Csic) (75%) Forma pseudopolimorfica de hidrocloruro de nicardipina, procedimiento para su preparacion y formulacion que la contiene.
EP2308483A4 (en) * 2008-07-01 2014-09-10 Sawai Seiyaku Kk PROCESS FOR PRODUCING SPHERICAL MICROPARTICLES COMPRISING TAMSULOSINE CHLORHYDRATE
CN101639340B (zh) * 2008-08-01 2011-01-12 广东省计量科学研究院 读数显微镜检定装置
SI2341899T1 (sl) * 2008-09-24 2015-04-30 Evonik Roehm Gmbh Od pH odvisen opioidni farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
JP2013501068A (ja) 2009-08-05 2013-01-10 アイディニックス ファーマシューティカルズ インコーポレイテッド 大環状セリンプロテアーゼ阻害剤
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
WO2011020610A1 (en) 2009-08-19 2011-02-24 Bayer Schering Pharma Aktiengesellschaft Drug delivery systems (wafer) for pediatric use
TWI491395B (zh) 2009-09-30 2015-07-11 Ct Lab Inc 一種內含用以治療神經退化性疾病之立即釋出與長效釋出藥物的口服劑量配方
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
US8362068B2 (en) 2009-12-18 2013-01-29 Idenix Pharmaceuticals, Inc. 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
ES2709766T3 (es) * 2010-03-09 2019-04-17 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas entéricas resistentes al alcohol
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
JP5648303B2 (ja) * 2010-03-19 2015-01-07 味の素株式会社 耐吸湿固結性を有する粉体造粒物の製造方法および粉体造粒物
KR101423237B1 (ko) * 2010-05-04 2014-07-30 주식회사 삼양바이오팜 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
CN103270030B (zh) 2010-09-01 2016-01-20 埃姆比特生物科学公司 吡唑基氨基喹唑啉的氢溴酸盐
JP5932794B2 (ja) 2010-09-01 2016-06-08 アムビト ビオスシエンセス コルポラチオン 光学活性のあるピラゾリルアミノキナゾリン及びその医薬組成物及び使用方法
JP2014500275A (ja) 2010-12-06 2014-01-09 フォリカ，インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
KR101111534B1 (ko) * 2010-12-24 2012-02-15 (주)비씨월드제약 구강 속붕해성 조성물 및 이의 제조방법
CN103338753A (zh) 2011-01-31 2013-10-02 细胞基因公司 胞苷类似物的药物组合物及其使用方法
TW201309690A (zh) 2011-02-10 2013-03-01 Idenix Pharmaceuticals Inc 巨環絲胺酸蛋白酶抑制劑，其醫藥組合物及其於治療ｈｃｖ感染之用途
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
WO2013019056A1 (en) * 2011-08-01 2013-02-07 Sam-A Pharm. Co., Ltd. Novel granule formulation containing sildenafil or pharmaceutically acceptable salts thereof as an active ingredient
US9901648B2 (en) 2012-01-27 2018-02-27 The Regents Of The University Of California Stabilization of biomolecules using sugar polymers
MX2014011115A (es) 2012-03-16 2015-03-13 Axikin Pharmaceuticals Inc Inhibidores de 3,5-diaminopirazol cinasa.
KR101931489B1 (ko) * 2012-10-12 2018-12-24 이에이 파마 가부시키가이샤 칼슘 길항약／안지오텐신 ｉｉ 수용체 길항약 함유 의약 제제의 제조 방법
PL2919903T3 (pl) 2012-11-14 2020-12-14 W.R. Grace & Co. - Conn. Kompozycje zawierające materiał biologicznie aktywny i nieuporządkowany tlenek nieorganiczny
CN103230379A (zh) * 2013-04-02 2013-08-07 万特制药(海南)有限公司 一种含有盐酸坦索罗辛的口崩缓释制剂及其制备方法
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
WO2015042375A1 (en) 2013-09-20 2015-03-26 Idenix Pharmaceuticals, Inc. Hepatitis c virus inhibitors
EP3114122A1 (en) 2014-03-05 2017-01-11 Idenix Pharmaceuticals LLC Solid forms of a flaviviridae virus inhibitor compound and salts thereof
TWI705967B (zh) 2014-03-20 2020-10-01 美商卡佩拉醫療公司 苯并咪唑衍生物及其醫藥組合物及使用方法
TWI683813B (zh) 2014-03-20 2020-02-01 美商卡佩拉醫療公司 苯并咪唑衍生物及其醫藥組合物及使用方法
US10335374B2 (en) * 2014-12-04 2019-07-02 University System of Georgia, Valdosta State University Tablet composition for anti-tuberculosis antibiotics
MY191736A (en) 2014-12-23 2022-07-13 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors
CZ2015225A3 (cs) * 2015-03-30 2016-10-12 Zentiva, K.S. Nový krok ve způsobu potahování pelet obsahujících Tamsulosin.HCI
JP2016193894A (ja) * 2015-04-01 2016-11-17 京都薬品工業株式会社 生菌含有製剤
JP6618736B2 (ja) * 2015-09-01 2019-12-11 沢井製薬株式会社 ミラベグロン含有錠剤、ミラベグロン含有製剤の製造方法及びミラベグロン含有造粒物の製造方法
KR102414503B1 (ko) 2016-03-17 2022-06-29 티오제네시스 테라퓨틱스, 인크. 시스테아민의 조절 방출을 위한 조성물 및 시스테아민 민감성 장애의 전신 치료
CN108066304B (zh) * 2016-11-16 2022-09-16 深圳万和制药有限公司 具有缓释性能的坦索罗辛口腔崩解片组合物
CN107616969B (zh) * 2016-11-16 2020-09-18 杭州朱养心药业有限公司 迅速崩解的吡仑帕奈片剂药物组合物
CN108066347B (zh) * 2016-11-16 2021-02-02 深圳万和制药有限公司 包含坦索罗辛和度他雄胺的口腔崩解片药物组合物
CN108066297B (zh) * 2016-11-16 2022-09-16 深圳万和制药有限公司 治疗老年痴呆症的定位释放美金刚口腔崩解片组合物
CN108066305B (zh) * 2016-11-16 2022-09-16 深圳万和制药有限公司 改善口崩片硬度和崩解的方法和定位释放口腔崩解片
WO2019039420A1 (ja) 2017-08-21 2019-02-28 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
WO2019151405A1 (ja) * 2018-02-02 2019-08-08 ニプロ株式会社 錠剤及びその製造方法
US20210113696A1 (en) * 2018-03-19 2021-04-22 Cage Bio Inc. Ionic liquid compositions for treatment of rosacea
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772475A (en) 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
JPH0780754B2 (ja) 1986-08-06 1995-08-30 エーザイ株式会社 多顆粒型持続性錠剤
JPH01135451A (ja) 1987-11-20 1989-05-29 Mitsubishi Electric Corp 搬送ロボット
DE69023654T2 (de) * 1989-08-25 1996-04-18 Bioglan Ireland R & D Ltd Pharmazeutische zusammensetzung und einnahmevorrichtung dafür.
DE69122280T2 (de) 1990-03-01 1997-04-24 Hewlett Packard Co Minimierung von Eluatbandbreiten in der Flüssigchromatographie
RU2109509C1 (ru) * 1991-12-24 1998-04-27 Яманути Фармасьютикал Ко., Лтд. Композиция для буккального введения лекарственного средства и способ ее получения
NZ278678A (en) 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
JPH1135451A (ja) 1994-07-27 1999-02-09 Yamanouchi Pharmaceut Co Ltd 口腔内溶解型錠剤およびその製造方法
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
HU224035B1 (hu) * 1996-05-13 2005-05-30 Novartis Consumer Health S.A. Bukkális adagolórendszer
DK0922464T3 (da) 1996-07-12 2005-06-06 Daiichi Seiyaku Co Hurtigt desintegrerbare, kompressionsstöbte materialer og fremgangsmåder til fremstilling af samme
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
JP4947833B2 (ja) 1997-07-25 2012-06-06 アルペックス・ファルマ・ソシエテ・アノニム 速崩壊性口内溶解錠の製造に適した顆粒の製造方法
BR9813808A (pt) * 1997-12-19 2002-05-28 Smithkline Beecham Corp Processo para produção de comprimidos para dispersão na mordida
KR100655627B1 (ko) 1998-03-16 2006-12-12 아스텔라스세이야쿠 가부시키가이샤 구강 내에서 급속히 붕괴되는 정제
US6465009B1 (en) 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6495177B1 (en) * 1999-08-13 2002-12-17 Warner Chilcott Laboratories Ireland Limited Orally dissolvable nutritional supplement
US20030104066A1 (en) 2000-03-27 2003-06-05 Kouji Murai Easy-to-take granules
US6872405B2 (en) * 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
MXPA03000985A (es) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Composicion que comprende particulas finas de liberacion sostenida para tabletas de desintegracion rapida en la cavidad bucal y metodo de fabricacion de la misma.

Also Published As

Publication number Publication date
KR20030036656A (ko) 2003-05-09
US7575762B2 (en) 2009-08-18
HUP0302351A2 (hu) 2003-10-28
ES2351249T3 (es) 2011-02-02
JP2004196829A (ja) 2004-07-15
CN1473035A (zh) 2004-02-04
CZ14921U1 (cs) 2004-11-23
JP4019374B2 (ja) 2007-12-12
HUP0302351A3 (en) 2007-03-28
EP1413294A4 (en) 2006-06-07
US7255876B2 (en) 2007-08-14
DE20220604U1 (de) 2004-02-26
KR100530546B1 (ko) 2005-11-23
US20030147948A1 (en) 2003-08-07
EP1413294A1 (en) 2004-04-28
ZA200300647B (en) 2004-07-14
CN1473035B (zh) 2012-07-18
EP1413294B1 (en) 2010-09-29
AU2002355222B2 (en) 2007-07-26
WO2003009831A1 (fr) 2003-02-06
DE60237826D1 (de) 2010-11-11
US20070202168A1 (en) 2007-08-30
CA2419089A1 (en) 2003-03-05
RU2245136C2 (ru) 2005-01-27
ATE482692T1 (de) 2010-10-15
JP2005206608A (ja) 2005-08-04
MXPA03000985A (es) 2004-04-02
BR0205509A (pt) 2003-06-24
JPWO2003009831A1 (ja) 2004-11-11

Similar Documents

Publication Publication Date Title
EP1413294A4 (en) COMPOSITION CONTAINING FINE GRAINS WITH DELAYED RELEASE FOR TABLETS FALLING FASTLY IN THE MOUTH CAVE AND PROCESS FOR THEIR PRODUCTION
AU2002355222A1 (en) Compositions containing sustained-release fine grains for tablets quickly disintegrable in the oral cavity and process for producing the same
HUP0204235A3 (en) Substituted glutarimides and use thereof il-12 production inhibitors, process for their preparation and pharmaceutical compositions containing them
MXPA02003122A (es) Acidos indolalcanoicos substituidos.
CA2384422A1 (en) Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants
HUP0302230A3 (en) Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
PL372561A1 (pl) Nowy preparat w postaci stałej, zawierający kopolimer blokowy oraz antracyklinowy czynnik przeciwrakowy i proces jego wytwarzania
CA2385130A1 (en) Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
WO2002047671A3 (en) Lactam compound to inhibit beta-amyloid peptide release or synthesis
HUP0303109A3 (en) Indolin-2-one derivatives, process for producing them and pharmaceutical compositions containing them
PL345215A1 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
AU2003242046A1 (en) Sustained-release composition, process for producing the same and preparation thereof
GB0206036D0 (en) Polishing composition and method for producing memory hard disk by means thereof
HUP0500137A2 (en) Pyrrolidine-2-ones as factor xa inhibitors, process for producing them and pharmaceutical compositions containing the same
HUP0400350A3 (en) Novel cyano-substituted dihydropyrimidine compounds, process for producing them, their use and pharmaceutical compositions containing them
IL148195A0 (en) Methods for producing agglomerate and tablets
WO2003063824A3 (en) Pharmaceutical composition
AP2004003045A0 (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same.
HUP0303737A3 (en) Indolinones, substituted in position 6, and their use as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
WO2002014313A3 (de) Neue beta-amyloid inhibitoren, verfahren zu deren herstellung und deren verwendung als arzneimittel
GB2377888B (en) Sustained release pharmaceutical composition containing glipizide and method for producing same
ATE233055T1 (de) Verfahren zur herstellung von zuckerfreien süsswaren
AU2002210632A1 (en) Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
AU2001277801A1 (en) Process for preparing 2,3-diaminopropanols and synthesis of other compounds using 2,3-diaminopropanols
AU2003223098A1 (en) Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed